From the Division of Plastic and Reconstructive Surgery, Washington University School of Medicine; the Department of Plastic and Reconstructive Surgery, Medical College of Wisconsin Affiliated Hospitals; Orthopaedics and the Department of Surgery, Uniformed Services University of the Health Sciences-Walter Reed National Military Medical Center; and the Department of Plastic and Reconstructive Surgery, The Ohio State University, Wexner Medical Center.
Plast Reconstr Surg. 2021 Jul 1;148(1):32e-41e. doi: 10.1097/PRS.0000000000008051.
Treatments to manage painful neuroma are needed. An operative strategy that isolates and controls chaotic axonal growth could prevent neuroma. Using long acellular nerve allograft to "cap" damaged nerve could control axonal regeneration and, in turn, regulate upstream gene expression patterns.
Rat sciatic nerve was transected, and the distal nerve end was reversed and ligated to generate a model end-neuroma. Three groups were used to assess their effects immediately following this nerve injury: no treatment (control), traction neurectomy, or 5-cm acellular nerve allograft cap attached to the proximal nerve. Regeneration of axons from the injured nerve was assessed over 5 months and paired with concurrent measurements of gene expression from upstream affected dorsal root ganglia.
Both control and traction neurectomy groups demonstrated uncontrolled axon regeneration revealed using Thy1-GFP rat axon imaging and histomorphometric measures of regenerated axons within the most terminal region of regenerated tissue. The acellular nerve allograft group arrested axons within the acellular nerve allograft, where no axons reached the most terminal region even after 5 months. At 5 months, gene expression associated with regeneration and pain sensitization, including Bdnf, cfos, and Gal, was decreased within dorsal root ganglia obtained from the acellular nerve allograft group compared to control or traction neurectomy group dorsal root ganglia.
Long acellular nerve allografts to cap a severed nerve arrested axon regeneration within the acellular nerve allograft. This growth arrest corresponded with changes in regenerative and pain-related genes upstream. Acellular nerve allografts may be useful for surgical intervention of neuroma.
需要治疗来管理疼痛性神经瘤。一种将混沌轴突生长隔离和控制的手术策略可以防止神经瘤的发生。使用长的去细胞神经移植物“帽”来覆盖受损的神经可以控制轴突再生,从而调节上游基因表达模式。
切断大鼠坐骨神经,将远端神经末端反转并结扎,以产生模型末端神经瘤。在神经损伤后立即使用三组来评估它们的效果:无治疗(对照组)、牵引神经切除术或 5cm 去细胞神经移植物帽附着在近端神经上。在 5 个月内评估损伤神经的轴突再生,并与受影响的背根神经节上游的基因表达进行同时测量。
对照组和牵引神经切除术组都显示出不受控制的轴突再生,这是通过使用 Thy1-GFP 大鼠轴突成像和再生组织最末端区域再生轴突的组织形态计量测量来揭示的。去细胞神经移植物组的轴突在去细胞神经移植物内被阻止,即使在 5 个月后,也没有轴突到达最末端区域。在 5 个月时,与再生和疼痛敏化相关的基因表达,包括 Bdnf、cfos 和 Gal,在来自去细胞神经移植物组的背根神经节中与对照组或牵引神经切除术组的背根神经节相比降低。
长的去细胞神经移植物帽状覆盖切断的神经,阻止了去细胞神经移植物内的轴突再生。这种生长阻滞与上游再生和疼痛相关基因的变化相对应。去细胞神经移植物可能对神经瘤的手术干预有用。